Top compounds associated with response to LRRC8C


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0007
mRNA AT7867 CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA BRD-K55116708 CTRPv2 pan-cancer AAC 0.13 0.0008
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0008
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0009
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.1 0.0009
mRNA clofarabine CTRPv2 pan-cancer AAC 0.098 0.001
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.001
mRNA bendamustine CTRPv2 pan-cancer AAC 0.12 0.002
mRNA narciclasine CTRPv2 pan-cancer AAC 0.1 0.002
Download CSV